Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Granins and prostate cancer

L J Deftos1, P A Abrahamsson

  • 1The Department of Medicine, University of California, San Diego 92161, USA. ljdeftos@ucsd.edu

Urology
|June 4, 1998
PubMed
Summary

Granin A (GRN-A) shows clinical value as a prostate cancer marker. Elevated serum GRN-A aids in diagnosing and predicting outcomes for early, progressive, and recurrent prostate cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[European Association of Urology. Position statement on screening for prostate cancer].

Actas urologicas espanolas·2010
Same author

Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel.

Annals of oncology : official journal of the European Society for Medical Oncology·2007
Same author

Coherent expression chromosome cluster analysis reveals differential regulatory functions of amino-terminal and distal parathyroid hormone-related protein domains in prostate carcinoma.

Journal of biomedicine & biotechnology·2006
Same author

Treatment of Paget's disease--taming the wild osteoclast.

The New England journal of medicine·2005
Same author

Chondrocyte calcium-sensing receptor expression is up-regulated in early guinea pig knee osteoarthritis and modulates PTHrP, MMP-13, and TIMP-3 expression.

Osteoarthritis and cartilage·2005
Same author

Monitoring of skeletal progression of prostate cancer by GFP imaging, X-ray, and serum OPG and PTHrP.

The Prostate·2004

Area of Science:

  • Oncology
  • Biochemistry
  • Urology

Background:

  • Granin A (GRN-A) expression is increasingly recognized in prostate cancer neuroendocrine differentiation.
  • Understanding GRN-A's role is crucial for advancing prostate cancer diagnostics and prognostics.

Purpose of the Study:

  • To investigate the clinical utility of Granin A (GRN-A) as a serum and tissue marker in prostate cancer.
  • To evaluate GRN-A's diagnostic and prognostic value in various stages of prostate cancer.

Main Methods:

  • Serum samples from prostate cancer patients were analyzed for GRN-A levels using immunoassay.
  • Immunohistology was employed to assess GRN-A expression in prostate tissue samples.
  • Clinical status and findings were correlated with serum and tissue GRN-A levels.

Main Results:

  • GRN-A serves as a valuable serum and tumor marker for prostate cancer diagnosis and prognosis.
  • Increased serum GRN-A levels were observed in both early and late-stage prostate cancer.
  • Elevated GRN-A identified patients with prostate cancer who had normal PSA levels, highlighting its independent diagnostic potential.
  • Higher serum GRN-A concentrations demonstrated prognostic significance.

Conclusions:

  • GRN-A holds significant clinical potential as a marker for early, progressive, and recurrent prostate cancer.
  • Both serum and tissue GRN-A show promise in clinical applications.
  • Further research is necessary to fully establish the clinical value of GRN-A in managing prostate cancer.

Related Experiment Videos